|
- Phage Therapy: Using Viruses to Defeat Antibiotic-Resistant Bacteria
Phage therapy: A renewed approach to combat antibiotic-resistant bacteria Cell Host Microbe 2019;25(2):219–232 Wright A, Hawkins CH, Änggård EE, Harper DR A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa Clin Otolaryngol 2009;34(4):349–357
- Multisite binding of bacteriophages on lipopolysaccharides in
Phage therapy offers an innovative strategy to combat antibiotic-resistant bacterial infections To address the challenge of phage-resistant strains, we can adopt two strategies: using phage cocktails targeting multiple bacterial receptors to delay resistance development; and implementing a 'phage shift' treatment strategy that exploits the adaptive trade-offs of phage-resistant bacteria
- AWS helps French biotech startup Phagos use AI to fight antibiotic . . .
That infrastructure is now the backbone of how Phagos plans to scale The more data it collects, the smarter its models become “Every time we deliver a new phage cocktail, we have more information, we have more biological resources,” said Pantalis “It improves our platform so that the next phage cocktail is better than the previous one ”
- Phage tRNAs: decoding the enigma: Trends in Microbiology - Cell Press
This benefits the temperate phage in inter-viral conflicts, as observed for E coli P2-like phages and their P4-like phage satellite, which encode phage defense systems in a specific integration site in their genome Lastly, besides possibly providing an advantage in inter-viral conflicts, temperate phage tRNAs may provide an advantage in
- Identification of immunogenic commensal antigens using phage . . . - Nature
For phage titration, take 10 μl of eluted phage from Step 67 and make 10-fold dilutions up to 10 −5 by using 2× YT medium 69 Add 50 μl of TG1 bacteria in each dilution and incubate at 37
- Bacteriophage Therapy As An Alternative To Antibiotics: A Meta-Analysis
Bacteriophage (phage) therapy, which employs viruses to target specific bacterial pathogens, is regaining attention as a promising solution for multidrug-resistant (MDR) infections Objective: This meta-analysis aims to evaluate the clinical efficacy, safety, and treatment outcomes associated with phage therapy in managing MDR bacterial infections
- Cracking the Code of Phages to Fight TB
By elucidating how Bxb1 overcomes these defenses, researchers can better comprehend phage-host interactions and identify key structural elements essential for effective infection The study’s findings also have practical implications for developing phage therapies against antibiotic-resistant TB By characterizing the structures of various
- BiomX Achieves Positive Phase 2 Results for BX211 in Treating Diabetic . . .
BiomX is dedicated to advancing medicine through the development of customized phage therapies aimed at eradicating harmful bacteria associated with chronic diseases such as cystic fibrosis and diabetic foot osteomyelitis The company focuses on discovering and validating proprietary bacterial targets and tailoring phage compositions to
|
|
|